College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health
Molecular Cellular and Biomedical Sciences
miR-205 Nanoparticle system circumvents docetaxel resistance in prostate cancer
PSMA Targeted Docetaxel Loaded Magnetic Nanoparticles for Prostate Cancer Therapy
Chauhan N, Manojkumar A, Jaggi M, Chauhan SC, Yallapu MM
Biochimica et biophysica acta. Reviews on cancer
Chauhan N, Manojkumar A, Jaggi M, Chauhan SC, Yallapu MM. microRNA-205 in prostate cancer: Overview to clinical translation. Biochim Biophys Acta Rev Cancer. 2022 11; 1877(6):188809.
microRNA-205 in prostate cancer: Overview to clinical translation.
Karthikeyan C, Jayaramudu T, N??ez D, Jara N, Opazo-Capurro A, Varaprasad K, Kim K, Yallapu MM, Sadiku R
International journal of biological macromolecules
Karthikeyan C, Jayaramudu T, N??ez D, Jara N, Opazo-Capurro A, Varaprasad K, Kim K, Yallapu MM, Sadiku R. Hybrid nanomaterial composed of chitosan, curcumin, ZnO and TiO2 for antibacterial therapies. Int J Biol Macromol. 2023 Jul 01; 242(Pt 2):124814.
Hybrid nanomaterial composed of chitosan, curcumin, ZnO and TiO2 for antibacterial therapies.
Dhasmana A, Dhasmana S, Agarwal S, Khan S, Haque S, Jaggi M, Yallapu MM, Chauhan SC
Computational and structural biotechnology journal
Dhasmana A, Dhasmana S, Agarwal S, Khan S, Haque S, Jaggi M, Yallapu MM, Chauhan SC. Integrative big transcriptomics data analysis implicates crucial role of MUC13 in pancreatic cancer. Comput Struct Biotechnol J. 2023; 21:2845-2857.
Integrative big transcriptomics data analysis implicates crucial role of MUC13 in pancreatic cancer.
Nagesh PKB, Chowdhury P, Hatami E, Kumari S, Kashyap VK, Tripathi MK, Wagh S, Meibohm B, Chauhan SC, Jaggi M, Yallapu MM
Nagesh PKB, Chowdhury P, Hatami E, Kumari S, Kashyap VK, Tripathi MK, Wagh S, Meibohm B, Chauhan SC, Jaggi M, Yallapu MM. Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence. ACS Appl Mater Interfaces. 2019 Oct 23; 11(42):38537-38554.
Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence.
Kumari S, Khan S, Sekhri R, Mandil H, Behrman S, Yallapu MM, Chauhan SC, Jaggi M
Kumari S, Khan S, Sekhri R, Mandil H, Behrman S, Yallapu MM, Chauhan SC, Jaggi M. Protein kinase D1 regulates metabolic switch in pancreatic cancer via modulation of mTORC1. Br J Cancer. 2020 01; 122(1):121-131.
Protein kinase D1 regulates metabolic switch in pancreatic cancer via modulation of mTORC1.
Dhasmana A, Dhasmana S, Alsulimani A, Kotnala S, Kashyap VK, Haque S, Jaggi M, Yallapu MM, Chauhan SC
Journal of King Saud University. Science
Dhasmana A, Dhasmana S, Alsulimani A, Kotnala S, Kashyap VK, Haque S, Jaggi M, Yallapu MM, Chauhan SC. In silico CD4 + T-cell multiepitope prediction and HLA distribution analysis for Marburg Virus-A strategy for vaccine designing. J King Saud Univ Sci. 2022 Feb; 34(2).
In silico CD4 + T-cell multiepitope prediction and HLA distribution analysis for Marburg Virus-A strategy for vaccine designing.
Mamidi N, Mostafavi E, Yallapu MM. Editorial: Exploring the potential of nanobiomaterials in biomedical engineering: assessing biocompatibility, toxicity, and future prospects. Front Chem. 2024; 12:1461483.
Editorial: Exploring the potential of nanobiomaterials in biomedical engineering: assessing biocompatibility, toxicity, and future prospects.
Rahimi H, Salehiabar M, Barsbay M, Ghaffarlou M, Kavetskyy T, Sharafi A, Davaran S, Chauhan SC, Danafar H, Kaboli S, Nosrati H, Yallapu MM, Conde J
Rahimi H, Salehiabar M, Barsbay M, Ghaffarlou M, Kavetskyy T, Sharafi A, Davaran S, Chauhan SC, Danafar H, Kaboli S, Nosrati H, Yallapu MM, Conde J. CRISPR Systems for COVID-19 Diagnosis. ACS Sens. 2021 04 23; 6(4):1430-1445.
Sikander M, Malik S, Rodriguez A, Yallapu MM, Narula AS, Satapathy SK, Dhevan V, Chauhan SC, Jaggi M
Sikander M, Malik S, Rodriguez A, Yallapu MM, Narula AS, Satapathy SK, Dhevan V, Chauhan SC, Jaggi M. Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules. 2020 Dec 13; 25(24).
Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction.
Chauhan DS, Dhasmana A, Laskar P, Prasad R, Jain NK, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Chauhan DS, Dhasmana A, Laskar P, Prasad R, Jain NK, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM. Nanotechnology synergized immunoengineering for cancer. Eur J Pharm Biopharm. 2021 Jun; 163:72-101.
Nanotechnology synergized immunoengineering for cancer.
Zhi K, Raji B, Nookala AR, Khan MM, Nguyen XH, Sakshi S, Pourmotabbed T, Yallapu MM, Kochat H, Tadrous E, Pernell S, Kumar S
Zhi K, Raji B, Nookala AR, Khan MM, Nguyen XH, Sakshi S, Pourmotabbed T, Yallapu MM, Kochat H, Tadrous E, Pernell S, Kumar S. PLGA Nanoparticle-Based Formulations to Cross the Blood-Brain Barrier for Drug Delivery: From R&D to cGMP. Pharmaceutics. 2021 Apr 06; 13(4).
PLGA Nanoparticle-Based Formulations to Cross the Blood-Brain Barrier for Drug Delivery: From R&D to cGMP.
Chowdhury P, Ghosh U, Samanta K, Jaggi M, Chauhan SC, Yallapu MM
Chowdhury P, Ghosh U, Samanta K, Jaggi M, Chauhan SC, Yallapu MM. Bioactive nanotherapeutic trends to combat triple negative breast cancer. Bioact Mater. 2021 Oct; 6(10):3269-3287.
Bioactive nanotherapeutic trends to combat triple negative breast cancer.
Massey AE, Malik S, Sikander M, Doxtater KA, Tripathi MK, Khan S, Yallapu MM, Jaggi M, Chauhan SC, Hafeez BB
International journal of molecular sciences
Massey AE, Malik S, Sikander M, Doxtater KA, Tripathi MK, Khan S, Yallapu MM, Jaggi M, Chauhan SC, Hafeez BB. Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment. Int J Mol Sci. 2021 May 17; 22(10).
Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment.
Chaib M, Hafeez BB, Mandil H, Daria D, Pingili AK, Kumari S, Sikander M, Kashyap VK, Chen GY, Anning E, Tripathi MK, Khan S, Behrman S, Yallapu MM, Jaggi M, Makowski L, Chauhan SC
Chaib M, Hafeez BB, Mandil H, Daria D, Pingili AK, Kumari S, Sikander M, Kashyap VK, Chen GY, Anning E, Tripathi MK, Khan S, Behrman S, Yallapu MM, Jaggi M, Makowski L, Chauhan SC. Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. Commun Biol. 2022 11 04; 5(1):1181.
Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore.
Cabrera M, Kolli M, Jaggi M, Chauhan SC, Yallapu MM
Cabrera M, Kolli M, Jaggi M, Chauhan SC, Yallapu MM. miRNA-205: a future therapeutic molecule for liver diseases. Future Drug Discov. 2023 Jan; 4(3):FDD78.
miRNA-205: a future therapeutic molecule for liver diseases.
Chauhan N, Maher DM, Hafeez BB, Mandil H, Singh MM, Yallapu MM, Jaggi M, Chauhan SC
Chauhan N, Maher DM, Hafeez BB, Mandil H, Singh MM, Yallapu MM, Jaggi M, Chauhan SC. Ormeloxifene nanotherapy for cervical cancer treatment. Int J Nanomedicine. 2019; 14:7107-7121.
Ormeloxifene nanotherapy for cervical cancer treatment.
Samanta K, Setua S, Kumari S, Jaggi M, Yallapu MM, Chauhan SC
Samanta K, Setua S, Kumari S, Jaggi M, Yallapu MM, Chauhan SC. Gemcitabine Combination Nano Therapies for Pancreatic Cancer. Pharmaceutics. 2019 Nov 04; 11(11).
Gemcitabine Combination Nano Therapies for Pancreatic Cancer.
Kashyap VK, Dan N, Chauhan N, Wang Q, Setua S, Nagesh PKB, Malik S, Batra V, Yallapu MM, Miller DD, Li W, Hafeez BB, Jaggi M, Chauhan SC
Kashyap VK, Dan N, Chauhan N, Wang Q, Setua S, Nagesh PKB, Malik S, Batra V, Yallapu MM, Miller DD, Li W, Hafeez BB, Jaggi M, Chauhan SC. VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway. Cancer Lett. 2020 02 01; 470:64-74.
VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway.
Massey AE, Doxtater KA, Yallapu MM, Chauhan SC
Massey AE, Doxtater KA, Yallapu MM, Chauhan SC. Biophysical changes caused by altered MUC13 expression in pancreatic cancer cells. Micron. 2020 03; 130:102822.
Biophysical changes caused by altered MUC13 expression in pancreatic cancer cells.
Doxtater K, Tripathi MK, Sekhri R, Hafeez BB, Khan S, Zafar N, Behrman SW, Yallapu MM, Jaggi M, Chauhan SC
Doxtater K, Tripathi MK, Sekhri R, Hafeez BB, Khan S, Zafar N, Behrman SW, Yallapu MM, Jaggi M, Chauhan SC. MUC13 drives cancer aggressiveness and metastasis through the YAP1-dependent pathway. Life Sci Alliance. 2023 12; 6(12).
MUC13 drives cancer aggressiveness and metastasis through the YAP1-dependent pathway.
Dhasmana S, Dhasmana A, Rios S, Enriquez-Perez IA, Khan S, Afaq F, Haque S, Manne U, Yallapu MM, Chauhan SC
Dhasmana S, Dhasmana A, Rios S, Enriquez-Perez IA, Khan S, Afaq F, Haque S, Manne U, Yallapu MM, Chauhan SC. An integrated computational biology approach defines the crucial role of TRIP13 in pancreatic cancer. Comput Struct Biotechnol J. 2023; 21:5765-5775.
An integrated computational biology approach defines the crucial role of TRIP13 in pancreatic cancer.
Nagesh PKB, Chowdhury P, Hatami E, Jain S, Dan N, Kashyap VK, Chauhan SC, Jaggi M, Yallapu MM
Nagesh PKB, Chowdhury P, Hatami E, Jain S, Dan N, Kashyap VK, Chauhan SC, Jaggi M, Yallapu MM. Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells. Sci Rep. 2020 01 22; 10(1):980.
Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells.
Chauhan SS, Shetty AB, Hatami E, Chowdhury P, Yallapu MM
Chauhan SS, Shetty AB, Hatami E, Chowdhury P, Yallapu MM. Pectin-Tannic Acid Nano-Complexes Promote the Delivery and Bioactivity of Drugs in Pancreatic Cancer Cells. Pharmaceutics. 2020 Mar 22; 12(3).
Pectin-Tannic Acid Nano-Complexes Promote the Delivery and Bioactivity of Drugs in Pancreatic Cancer Cells.
Shetty A, Nagesh PKB, Setua S, Hafeez BB, Jaggi M, Yallapu MM, Chauhan SC
Shetty A, Nagesh PKB, Setua S, Hafeez BB, Jaggi M, Yallapu MM, Chauhan SC. Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy. ACS Omega. 2020 Apr 21; 5(15):8982-8991.
Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy.
Dhasmana A, Uniyal S, Kashyap VK, Somvanshi P, Gupta M, Bhardwaj U, Jaggi M, Yallapu MM, Haque S, Chauhan SC
Dhasmana A, Uniyal S, Kashyap VK, Somvanshi P, Gupta M, Bhardwaj U, Jaggi M, Yallapu MM, Haque S, Chauhan SC. Topological and system-level protein interaction network (PIN) analyses to deduce molecular mechanism of curcumin. Sci Rep. 2020 07 21; 10(1):12045.
Topological and system-level protein interaction network (PIN) analyses to deduce molecular mechanism of curcumin.
Chauhan N, Dhasmana A, Jaggi M, Chauhan SC, Yallapu MM
Chauhan N, Dhasmana A, Jaggi M, Chauhan SC, Yallapu MM. miR-205: A Potential Biomedicine for Cancer Therapy. Cells. 2020 08 25; 9(9).
miR-205: A Potential Biomedicine for Cancer Therapy.
Dhasmana A, Kashyap VK, Dhasmana S, Kotnala S, Haque S, Ashraf GM, Jaggi M, Yallapu MM, Chauhan SC
Dhasmana A, Kashyap VK, Dhasmana S, Kotnala S, Haque S, Ashraf GM, Jaggi M, Yallapu MM, Chauhan SC. Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach. Curr Pharm Des. 2020; 26(41):5300-5309.
Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach.
Tiwari R, Kolli M, Chauhan S, Yallapu MM
Tiwari R, Kolli M, Chauhan S, Yallapu MM. Tabletized Nanomedicine: From the Current Scenario to Developing Future Medicine. ACS Nano. 2024 05 07; 18(18):11503-11524.
Tabletized Nanomedicine: From the Current Scenario to Developing Future Medicine.
Setua S, Shabir S, Shaji P, Bulnes AM, Dhasmana A, Holla S, Mittal NK, Sahoo N, Saini T, Giorgianni F, Sikander M, Massey AE, Hafeez BB, Tripathi MK, Diego VP, Jaggi M, Yue J, Zafar N, Yallapu MM, Behrman SW, Khan S, Chauhan SC
Setua S, Shabir S, Shaji P, Bulnes AM, Dhasmana A, Holla S, Mittal NK, Sahoo N, Saini T, Giorgianni F, Sikander M, Massey AE, Hafeez BB, Tripathi MK, Diego VP, Jaggi M, Yue J, Zafar N, Yallapu MM, Behrman SW, Khan S, Chauhan SC. Exosomes derived from tumor adjacent fibroblasts efficiently target pancreatic tumors. Acta Pharm Sin B. 2024 Jul; 14(7):3009-3026.
Exosomes derived from tumor adjacent fibroblasts efficiently target pancreatic tumors.
Cotto NM, Chauhan N, Adriano B, Chauhan DS, Cabrera M, Chauhan SC, Yallapu MM
Cotto NM, Chauhan N, Adriano B, Chauhan DS, Cabrera M, Chauhan SC, Yallapu MM. Milk Exosome-Glow Nanosystem for Cancer Cellular and Tissue Bioimaging. Chem Biomed Imaging. 2024 Oct 28; 2(10):711-720.
Milk Exosome-Glow Nanosystem for Cancer Cellular and Tissue Bioimaging.
Kotnala S, Dhasmana A, Kashyap VK, Chauhan SC, Yallapu MM, Jaggi M
Kotnala S, Dhasmana A, Kashyap VK, Chauhan SC, Yallapu MM, Jaggi M. A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder. Life Sci. 2021 Mar 01; 268:118959.
A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder.
Yallapu MM, Maher DM, Sundram V, Bell MC, Jaggi M, Chauhan SC
Yallapu MM, Maher DM, Sundram V, Bell MC, Jaggi M, Chauhan SC. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res. 2010 Apr 29; 3:11.
Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth.
Yallapu MM, Jaggi M, Chauhan SC. Poly(?-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. Macromol Biosci. 2010 Oct 08; 10(10):1141-51.
Poly(?-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells.
Yallapu MM, Jaggi M, Chauhan SC. Scope of nanotechnology in ovarian cancer therapeutics. J Ovarian Res. 2010 Aug 06; 3:19.
Scope of nanotechnology in ovarian cancer therapeutics.
Yallapu MM, Gupta BK, Jaggi M, Chauhan SC
Journal of colloid and interface science
Yallapu MM, Gupta BK, Jaggi M, Chauhan SC. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci. 2010 Nov 01; 351(1):19-29.
Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Anilkumar AK, Vij P, Lopez S, Leslie SM, Doxtater K, Khan MM, Yallapu MM, Chauhan SC, Maestre GE, Tripathi MK
Anilkumar AK, Vij P, Lopez S, Leslie SM, Doxtater K, Khan MM, Yallapu MM, Chauhan SC, Maestre GE, Tripathi MK. Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases. Int J Mol Sci. 2024 Feb 14; 25(4).
Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases.
Verma A, Manojkumar A, Dhasmana A, Tripathi MK, Jaggi M, Chauhan SC, Chauhan DS, Yallapu MM
Verma A, Manojkumar A, Dhasmana A, Tripathi MK, Jaggi M, Chauhan SC, Chauhan DS, Yallapu MM. Recurring SARS-CoV-2 variants: an update on post-pandemic, co-infections and immune response. Nanotheranostics. 2024; 8(2):247-269.
Recurring SARS-CoV-2 variants: an update on post-pandemic, co-infections and immune response.
Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC
Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials. 2011 Mar; 32(7):1890-905.
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy.
Yallapu MM, Dobberpuhl MR, Maher DM, Jaggi M, Chauhan SC
Yallapu MM, Dobberpuhl MR, Maher DM, Jaggi M, Chauhan SC. Design of curcumin loaded cellulose nanoparticles for prostate cancer. Curr Drug Metab. 2012 Jan; 13(1):120-8.
Design of curcumin loaded cellulose nanoparticles for prostate cancer.
Yallapu MM, Ebeling MC, Chauhan N, Jaggi M, Chauhan SC
Yallapu MM, Ebeling MC, Chauhan N, Jaggi M, Chauhan SC. Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes. Int J Nanomedicine. 2011; 6:2779-90.
Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes.
Gong Y, Zhi K, Nagesh PKB, Sinha N, Chowdhury P, Chen H, Gorantla S, Yallapu MM, Kumar S
Gong Y, Zhi K, Nagesh PKB, Sinha N, Chowdhury P, Chen H, Gorantla S, Yallapu MM, Kumar S. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia. Viruses. 2020 05 20; 12(5).
An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
Hatami E, Jaggi M, Chauhan SC, Yallapu MM
Hatami E, Jaggi M, Chauhan SC, Yallapu MM. Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics. Biochim Biophys Acta Rev Cancer. 2020 08; 1874(1):188381.
Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics.
Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today. 2012 Jan; 17(1-2):71-80.
Curcumin nanoformulations: a future nanomedicine for cancer.
Moreland R, Arredondo A, Dhasmana A, Dhasmana S, Shabir S, Siddiqua A, Banerjee B, Yallapu MM, Behrman SW, Chauhan SC, Khan S
Moreland R, Arredondo A, Dhasmana A, Dhasmana S, Shabir S, Siddiqua A, Banerjee B, Yallapu MM, Behrman SW, Chauhan SC, Khan S. Correction: Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research. Front Pharmacol. 2025; 16:1662270.
Correction: Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research.
Gara RK, Kumari S, Ganju A, Yallapu MM, Jaggi M, Chauhan SC
Gara RK, Kumari S, Ganju A, Yallapu MM, Jaggi M, Chauhan SC. Slit/Robo pathway: a promising therapeutic target for cancer. Drug Discov Today. 2015 Jan; 20(1):156-64.
Slit/Robo pathway: a promising therapeutic target for cancer.
Thomas V, Yallapu MM, Sreedhar B, Bajpai SK
Thomas V, Yallapu MM, Sreedhar B, Bajpai SK. A versatile strategy to fabricate hydrogel-silver nanocomposites and investigation of their antimicrobial activity. J Colloid Interface Sci. 2007 Nov 01; 315(1):389-95.
A versatile strategy to fabricate hydrogel-silver nanocomposites and investigation of their antimicrobial activity.
Journal of biomaterials science. Polymer edition
Thomas V, Yallapu MM, Sreedhar B, Bajpai SK. Fabrication, characterization of chitosan/nanosilver film and its potential antibacterial application. J Biomater Sci Polym Ed. 2009; 20(14):2129-44.
Fabrication, characterization of chitosan/nanosilver film and its potential antibacterial application.
Reddy MK, Vasir JK, Sahoo SK, Jain TK, Yallapu MM, Labhasetwar V
Circulation. Cardiovascular interventions
Reddy MK, Vasir JK, Sahoo SK, Jain TK, Yallapu MM, Labhasetwar V. Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured artery. Circ Cardiovasc Interv. 2008 Dec; 1(3):209-16.
Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured artery.
Yallapu MM, Jaggi M, Chauhan SC. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces. 2010 Aug 01; 79(1):113-25.
beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
Yallapu MM, Foy SP, Jain TK, Labhasetwar V
Yallapu MM, Foy SP, Jain TK, Labhasetwar V. PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pharm Res. 2010 Nov; 27(11):2283-95.
PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications.
Yallapu MM, Jaggi M, Chauhan SC. Design and engineering of nanogels for cancer treatment. Drug Discov Today. 2011 May; 16(9-10):457-63.
Design and engineering of nanogels for cancer treatment.
Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanomedicine: a road to cancer therapeutics. Curr Pharm Des. 2013; 19(11):1994-2010.
Curcumin nanomedicine: a road to cancer therapeutics.
Varaprasad K, Raghavendra GM, Jayaramudu T, Yallapu MM, Sadiku R
Materials science & engineering. C, Materials for biological applications
Varaprasad K, Raghavendra GM, Jayaramudu T, Yallapu MM, Sadiku R. A mini review on hydrogels classification and recent developments in miscellaneous applications. Mater Sci Eng C Mater Biol Appl. 2017 Oct 01; 79:958-971.
A mini review on hydrogels classification and recent developments in miscellaneous applications.
Chauhan N, Cabrera M, Chowdhury P, Nagesh PKB, Dhasmana A, Jaggi M, Chauhan SC, Yallapu MM
Chauhan N, Cabrera M, Chowdhury P, Nagesh PKB, Dhasmana A, Jaggi M, Chauhan SC, Yallapu MM. Indocyanine Green-based Glow Nanoparticles Probe for Cancer Imaging. Nanotheranostics. 2023; 7(4):353-367.
Indocyanine Green-based Glow Nanoparticles Probe for Cancer Imaging.
Laskar P, Dhasmana A, Kotnala S, Jaggi M, Yallapu MM, Chauhan SC
Laskar P, Dhasmana A, Kotnala S, Jaggi M, Yallapu MM, Chauhan SC. Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy. Pharmaceutics. 2023 Apr 24; 15(5).
Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy.
Karthikeyan C, Tharmalingam N, Varaprasad K, Mylonakis E, Yallapu MM
Karthikeyan C, Tharmalingam N, Varaprasad K, Mylonakis E, Yallapu MM. Biocidal and biocompatible hybrid nanomaterials from biomolecule chitosan, alginate and ZnO. Carbohydr Polym. 2021 Nov 15; 274:118646.
Biocidal and biocompatible hybrid nanomaterials from biomolecule chitosan, alginate and ZnO.
Sahay P, Ganju A, Almabadi HM, Ghimire HM, Yallapu MM, Skalli O, Jaggi M, Chauhan SC, Pradhan P
Sahay P, Ganju A, Almabadi HM, Ghimire HM, Yallapu MM, Skalli O, Jaggi M, Chauhan SC, Pradhan P. Quantification of photonic localization properties of targeted nuclear mass density variations: Application in cancer-stage detection. J Biophotonics. 2018 05; 11(5):e201700257.
Quantification of photonic localization properties of targeted nuclear mass density variations: Application in cancer-stage detection.
Karumuru V, Dhasmana A, Mamidi N, Chauhan SC, Yallapu MM
Karumuru V, Dhasmana A, Mamidi N, Chauhan SC, Yallapu MM. Unveiling the potential of Urolithin A in Cancer Therapy: Mechanistic Insights to Future Perspectives of Nanomedicine. Nanotheranostics. 2025; 9(2):121-143.
Unveiling the potential of Urolithin A in Cancer Therapy: Mechanistic Insights to Future Perspectives of Nanomedicine.
Ganju A, Chauhan SC, Hafeez BB, Doxtater K, Tripathi MK, Zafar N, Yallapu MM, Kumar R, Jaggi M
Ganju A, Chauhan SC, Hafeez BB, Doxtater K, Tripathi MK, Zafar N, Yallapu MM, Kumar R, Jaggi M. Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1. Br J Cancer. 2018 02 20; 118(4):587-599.
Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.
Kumari S, Khan S, Gupta SC, Kashyap VK, Yallapu MM, Chauhan SC, Jaggi M
Kumari S, Khan S, Gupta SC, Kashyap VK, Yallapu MM, Chauhan SC, Jaggi M. MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. Oncogenesis. 2018 Feb 22; 7(2):19.
MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer.
Tripathi MK, Doxtater K, Keramatnia F, Zacheaus C, Yallapu MM, Jaggi M, Chauhan SC
Tripathi MK, Doxtater K, Keramatnia F, Zacheaus C, Yallapu MM, Jaggi M, Chauhan SC. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes. Drug Discov Today. 2018 09; 23(9):1635-1643.
Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes.
Dhasmana A, Dhasmana S, Haque S, Cobos E, Yallapu MM, Chauhan SC
Dhasmana A, Dhasmana S, Haque S, Cobos E, Yallapu MM, Chauhan SC. Next-generation immune checkpoint inhibitors as promising functional molecules in cancer therapeutics. Cancer Metastasis Rev. 2023 09; 42(3):597-600.
Next-generation immune checkpoint inhibitors as promising functional molecules in cancer therapeutics.
Sikander M, Malik S, Apraku J, Kumari S, Khan P, Mandil H, Ganju A, Chauhan B, Bell MC, Singh MM, Khan S, Yallapu MM, Halaweish FT, Jaggi M, Chauhan SC
Sikander M, Malik S, Apraku J, Kumari S, Khan P, Mandil H, Ganju A, Chauhan B, Bell MC, Singh MM, Khan S, Yallapu MM, Halaweish FT, Jaggi M, Chauhan SC. Synthesis and Antitumor Activity of Brominated-Ormeloxifene (Br-ORM) against Cervical Cancer. ACS Omega. 2023 Oct 24; 8(42):38839-38848.
Synthesis and Antitumor Activity of Brominated-Ormeloxifene (Br-ORM) against Cervical Cancer.
Yallapu MM, Ebeling MC, Jaggi M, Chauhan SC
Yallapu MM, Ebeling MC, Jaggi M, Chauhan SC. Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. Curr Drug Metab. 2013 May; 14(4):504-15.
Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics.
Khan S, Banerjee G, Setua S, Jones DH, Chauhan BV, Dhasmana A, Banerjee P, Yallapu MM, Behrman S, Chauhan SC
Khan S, Banerjee G, Setua S, Jones DH, Chauhan BV, Dhasmana A, Banerjee P, Yallapu MM, Behrman S, Chauhan SC. Metagenomic analysis unveils the microbial landscape of pancreatic tumors. Front Microbiol. 2023; 14:1275374.
Metagenomic analysis unveils the microbial landscape of pancreatic tumors.
Ghali ENHK, Chauhan SC, Yallapu MM. Inulin-based formulations as an emerging therapeutic strategy for cancer: A comprehensive review. Int J Biol Macromol. 2024 Feb; 259(Pt 1):129216.
Inulin-based formulations as an emerging therapeutic strategy for cancer: A comprehensive review.
Chavda VP, Ghali ENHK, Balar PC, Chauhan SC, Tiwari N, Shukla S, Athalye M, Patravale V, Apostolopoulos V, Yallapu MM
Journal of controlled release : official journal of the Controlled Release Society
Chavda VP, Ghali ENHK, Balar PC, Chauhan SC, Tiwari N, Shukla S, Athalye M, Patravale V, Apostolopoulos V, Yallapu MM. Protein subunit vaccines: Promising frontiers against COVID-19. J Control Release. 2024 02; 366:761-782.
Protein subunit vaccines: Promising frontiers against COVID-19.
Malik S, Sikander M, Wahid M, Dhasmana A, Sarwat M, Khan S, Cobos E, Yallapu MM, Jaggi M, Chauhan SC
Malik S, Sikander M, Wahid M, Dhasmana A, Sarwat M, Khan S, Cobos E, Yallapu MM, Jaggi M, Chauhan SC. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance. Cancer Metastasis Rev. 2024 Sep; 43(3):981-999.
Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance.
Kotnala S, Dhasmana A, Dhasmana S, Haque S, Yallapu MM, Tripathi MK, Jaggi M, Chauhan SC
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer
Kotnala S, Dhasmana A, Dhasmana S, Haque S, Yallapu MM, Tripathi MK, Jaggi M, Chauhan SC. A Systems Biology Approach Unveils a Critical Role of DPP4 in Upper Gastrointestinal Cancer Patient Outcomes. J Environ Pathol Toxicol Oncol. 2024; 43(2):43-55.
A Systems Biology Approach Unveils a Critical Role of DPP4 in Upper Gastrointestinal Cancer Patient Outcomes.
Yallapu MM, Othman SF, Curtis ET, Bauer NA, Chauhan N, Kumar D, Jaggi M, Chauhan SC
Yallapu MM, Othman SF, Curtis ET, Bauer NA, Chauhan N, Kumar D, Jaggi M, Chauhan SC. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine. 2012; 7:1761-79.
Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications.
Ahmad M, Alvi SS, Dhasmana A, Benavidez J, Yallapu MM, Kim DJ, Chauhan SC, Hafeez BB
Ahmad M, Alvi SS, Dhasmana A, Benavidez J, Yallapu MM, Kim DJ, Chauhan SC, Hafeez BB. Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic cancer. Transl Oncol. 2025 Aug; 58:102432.
Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic cancer.
Yallapu MM, Katti KS, Katti DR, Mishra SR, Khan S, Jaggi M, Chauhan SC
Yallapu MM, Katti KS, Katti DR, Mishra SR, Khan S, Jaggi M, Chauhan SC. The roles of cellular nanomechanics in cancer. Med Res Rev. 2015 Jan; 35(1):198-223.
The roles of cellular nanomechanics in cancer.
Khan S, Ebeling MC, Zaman MS, Sikander M, Yallapu MM, Chauhan N, Yacoubian AM, Behrman SW, Zafar N, Kumar D, Thompson PA, Jaggi M, Chauhan SC
Khan S, Ebeling MC, Zaman MS, Sikander M, Yallapu MM, Chauhan N, Yacoubian AM, Behrman SW, Zafar N, Kumar D, Thompson PA, Jaggi M, Chauhan SC. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. Oncotarget. 2014 Sep 15; 5(17):7599-609.
MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.
Yallapu MM, Nagesh PK, Jaggi M, Chauhan SC
Yallapu MM, Nagesh PK, Jaggi M, Chauhan SC. Therapeutic Applications of Curcumin Nanoformulations. AAPS J. 2015 Nov; 17(6):1341-56.
Therapeutic Applications of Curcumin Nanoformulations.
Zaman MS, Chauhan N, Yallapu MM, Gara RK, Maher DM, Kumari S, Sikander M, Khan S, Zafar N, Jaggi M, Chauhan SC
Zaman MS, Chauhan N, Yallapu MM, Gara RK, Maher DM, Kumari S, Sikander M, Khan S, Zafar N, Jaggi M, Chauhan SC. Curcumin Nanoformulation for Cervical Cancer Treatment. Sci Rep. 2016 Feb 03; 6:20051.
Curcumin Nanoformulation for Cervical Cancer Treatment.
Khan S, Ebeling MC, Chauhan N, Thompson PA, Gara RK, Ganju A, Yallapu MM, Behrman SW, Zhao H, Zafar N, Singh MM, Jaggi M, Chauhan SC
Khan S, Ebeling MC, Chauhan N, Thompson PA, Gara RK, Ganju A, Yallapu MM, Behrman SW, Zhao H, Zafar N, Singh MM, Jaggi M, Chauhan SC. Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer. Cancer Res. 2015 Jun 01; 75(11):2292-304.
Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer.
Gong Y, Chowdhury P, Nagesh PKB, Cory TJ, Dezfuli C, Kodidela S, Singh A, Yallapu MM, Kumar S
Gong Y, Chowdhury P, Nagesh PKB, Cory TJ, Dezfuli C, Kodidela S, Singh A, Yallapu MM, Kumar S. Nanotechnology approaches for delivery of cytochrome P450 substrates in HIV treatment. Expert Opin Drug Deliv. 2019 08; 16(8):869-882.
Nanotechnology approaches for delivery of cytochrome P450 substrates in HIV treatment.
Setua S, Khan S, Yallapu MM, Behrman SW, Sikander M, Khan SS, Jaggi M, Chauhan SC
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Setua S, Khan S, Yallapu MM, Behrman SW, Sikander M, Khan SS, Jaggi M, Chauhan SC. Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy. J Gastrointest Surg. 2017 01; 21(1):94-105.
Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy.
Boya VN, Lovett R, Setua S, Gandhi V, Nagesh PKB, Khan S, Jaggi M, Yallapu MM, Chauhan SC
Boya VN, Lovett R, Setua S, Gandhi V, Nagesh PKB, Khan S, Jaggi M, Yallapu MM, Chauhan SC. Probing mucin interaction behavior of magnetic nanoparticles. J Colloid Interface Sci. 2017 Feb 15; 488:258-268.
Probing mucin interaction behavior of magnetic nanoparticles.
Ganju A, Khan S, Hafeez BB, Behrman SW, Yallapu MM, Chauhan SC, Jaggi M
Ganju A, Khan S, Hafeez BB, Behrman SW, Yallapu MM, Chauhan SC, Jaggi M. miRNA nanotherapeutics for cancer. Drug Discov Today. 2017 02; 22(2):424-432.
Nagesh PKB, Johnson NR, Boya VKN, Chowdhury P, Othman SF, Khalilzad-Sharghi V, Hafeez BB, Ganju A, Khan S, Behrman SW, Zafar N, Chauhan SC, Jaggi M, Yallapu MM
Nagesh PKB, Johnson NR, Boya VKN, Chowdhury P, Othman SF, Khalilzad-Sharghi V, Hafeez BB, Ganju A, Khan S, Behrman SW, Zafar N, Chauhan SC, Jaggi M, Yallapu MM. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer. Colloids Surf B Biointerfaces. 2016 Aug 01; 144:8-20.
PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
Hafeez BB, Ganju A, Sikander M, Kashyap VK, Hafeez ZB, Chauhan N, Malik S, Massey AE, Tripathi MK, Halaweish FT, Zafar N, Singh MM, Yallapu MM, Chauhan SC, Jaggi M
Hafeez BB, Ganju A, Sikander M, Kashyap VK, Hafeez ZB, Chauhan N, Malik S, Massey AE, Tripathi MK, Halaweish FT, Zafar N, Singh MM, Yallapu MM, Chauhan SC, Jaggi M. Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic ?-catenin Signaling and EMT Progression. Mol Cancer Ther. 2017 10; 16(10):2267-2280.
Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic ?-catenin Signaling and EMT Progression.
Laskar P, Jaggi M, Chauhan SC, Yallapu MM
Laskar P, Jaggi M, Chauhan SC, Yallapu MM. Biomolecule-functionalized nanoformulations for prostate cancer theranostics. J Adv Res. 2023 09; 51:197-217.
Biomolecule-functionalized nanoformulations for prostate cancer theranostics.
Martin EA, Chauhan N, Dhevan V, George E, Laskar P, Jaggi M, Chauhan SC, Yallapu MM
Martin EA, Chauhan N, Dhevan V, George E, Laskar P, Jaggi M, Chauhan SC, Yallapu MM. Current status of biopsy markers for the breast in clinical settings. Expert Rev Med Devices. 2022 Dec; 19(12):965-975.
Current status of biopsy markers for the breast in clinical settings.
Dhasmana A, Dhasmana S, Kotnala S, Laskar P, Khan S, Haque S, Jaggi M, Yallapu MM, Chauhan SC
Dhasmana A, Dhasmana S, Kotnala S, Laskar P, Khan S, Haque S, Jaggi M, Yallapu MM, Chauhan SC. CEACAM7 expression contributes to early events of pancreatic cancer. J Adv Res. 2024 01; 55:61-72.
CEACAM7 expression contributes to early events of pancreatic cancer.
Sikander M, Malik S, Khan S, Kumari S, Chauhan N, Khan P, Halaweish FT, Chauhan B, Yallapu MM, Jaggi M, Chauhan SC
Sikander M, Malik S, Khan S, Kumari S, Chauhan N, Khan P, Halaweish FT, Chauhan B, Yallapu MM, Jaggi M, Chauhan SC. Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer). Cells. 2019 Dec 31; 9(1).
Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer).
Chauhan N, Kruse A, Newby H, Jaggi M, Yallapu MM, Chauhan SC
Chauhan N, Kruse A, Newby H, Jaggi M, Yallapu MM, Chauhan SC. Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells. ACS Omega. 2020 Jan 21; 5(2):1147-1156.
Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells.
Yadav HM, Thorat ND, Yallapu MM, Tofail SAM, Kim JS
Yadav HM, Thorat ND, Yallapu MM, Tofail SAM, Kim JS. Functional TiO2 nanocoral architecture for light-activated cancer chemotherapy. J Mater Chem B. 2017 Feb 21; 5(7):1461-1470.
Functional TiO2 nanocoral architecture for light-activated cancer chemotherapy.
Laskar P, Yallapu MM, Chauhan SC. "Tomorrow Never Dies": Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies. Diseases. 2020 Aug 06; 8(3).
"Tomorrow Never Dies": Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies.
Kashyap VK, Dhasmana A, Yallapu MM, Chauhan SC, Jaggi M
Kashyap VK, Dhasmana A, Yallapu MM, Chauhan SC, Jaggi M. Withania somnifera as a potential future drug molecule for COVID-19. Future Drug Discov. 2020 Oct 01; 2(4):FDD50.
Withania somnifera as a potential future drug molecule for COVID-19.
Varaprasad K, Nunez D, Yallapu MM, Jayaramudu T, Elgueta E, Oyarzun P
Varaprasad K, Nunez D, Yallapu MM, Jayaramudu T, Elgueta E, Oyarzun P. Nano-hydroxyapatite polymeric hydrogels for dye removal. RSC Adv. 2018 May 16; 8(32):18118-18127.
Nano-hydroxyapatite polymeric hydrogels for dye removal.
Gong Y, Chowdhury P, Midde NM, Rahman MA, Yallapu MM, Kumar S
Gong Y, Chowdhury P, Midde NM, Rahman MA, Yallapu MM, Kumar S. Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages. Biochem Biophys Rep. 2017 Dec; 12:214-219.
Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages.
Khan S, Zafar N, Khan SS, Setua S, Behrman SW, Stiles ZE, Yallapu MM, Sahay P, Ghimire H, Ise T, Nagata S, Wang L, Wan JY, Pradhan P, Jaggi M, Chauhan SC
HPB : the official journal of the International Hepato Pancreato Biliary Association
Khan S, Zafar N, Khan SS, Setua S, Behrman SW, Stiles ZE, Yallapu MM, Sahay P, Ghimire H, Ise T, Nagata S, Wang L, Wan JY, Pradhan P, Jaggi M, Chauhan SC. Clinical significance of MUC13 in pancreatic ductal adenocarcinoma. HPB (Oxford). 2018 06; 20(6):563-572.
Clinical significance of MUC13 in pancreatic ductal adenocarcinoma.
Almabadi HM, Nagesh PKB, Sahay P, Bhandari S, Eckstein EC, Jaggi M, Chauhan SC, Yallapu MM, Pradhan P
Almabadi HM, Nagesh PKB, Sahay P, Bhandari S, Eckstein EC, Jaggi M, Chauhan SC, Yallapu MM, Pradhan P. Optical study of chemotherapy efficiency in cancer treatment via intracellular structural disorder analysis using partial wave spectroscopy. J Biophotonics. 2018 12; 11(12):e201800056.
Optical study of chemotherapy efficiency in cancer treatment via intracellular structural disorder analysis using partial wave spectroscopy.
Ghali ENHK, Chauhan N, Tiwari R, Cabrera M, Chauhan SC, Yallapu MM
Ghali ENHK, Chauhan N, Tiwari R, Cabrera M, Chauhan SC, Yallapu MM. One-step simultaneous liquid phase exfoliation-induced chirality in graphene and their chirality-mediated microRNA delivery. Mater Adv. 2023 Nov 27; 4(23):6199-6212.
One-step simultaneous liquid phase exfoliation-induced chirality in graphene and their chirality-mediated microRNA delivery.
Hatami E, Nagesh PKB, Chowdhury P, Chauhan SC, Jaggi M, Samarasinghe AE, Yallapu MM
Hatami E, Nagesh PKB, Chowdhury P, Chauhan SC, Jaggi M, Samarasinghe AE, Yallapu MM. Tannic Acid-Lung Fluid Assemblies Promote Interaction and Delivery of Drugs to Lung Cancer Cells. Pharmaceutics. 2018 Aug 01; 10(3).
Tannic Acid-Lung Fluid Assemblies Promote Interaction and Delivery of Drugs to Lung Cancer Cells.
Chowdhury P, Nagesh PKB, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM
Chowdhury P, Nagesh PKB, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM. Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer. Acta Pharm Sin B. 2018 Jul; 8(4):602-614.
Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer.
Malik S, Sikander M, Bell N, Zubieta D, Bell MC, Yallapu MM, Chauhan SC
Malik S, Sikander M, Bell N, Zubieta D, Bell MC, Yallapu MM, Chauhan SC. Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy. J Ovarian Res. 2024 Aug 08; 17(1):161.
Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy.
Kashyap VK, Sharma BP, Pandey D, Singh AK, Peasah-Darkwah G, Singh B, Roy KK, Yallapu MM, Chauhan SC
Kashyap VK, Sharma BP, Pandey D, Singh AK, Peasah-Darkwah G, Singh B, Roy KK, Yallapu MM, Chauhan SC. Small Molecule with Big Impact: Metarrestin Targets the Perinucleolar Compartment in Cancer Metastasis. Cells. 2024 12 12; 13(24).
Small Molecule with Big Impact: Metarrestin Targets the Perinucleolar Compartment in Cancer Metastasis.
Massey AE, Sikander M, Chauhan N, Kumari S, Setua S, Shetty AB, Mandil H, Kashyap VK, Khan S, Jaggi M, Yallapu MM, Hafeez BB, Chauhan SC
Nanomedicine : nanotechnology, biology, and medicine
Massey AE, Sikander M, Chauhan N, Kumari S, Setua S, Shetty AB, Mandil H, Kashyap VK, Khan S, Jaggi M, Yallapu MM, Hafeez BB, Chauhan SC. Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. Nanomedicine. 2019 08; 20:102027.
Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment.
Sikander M, Hafeez BB, Malik S, Alsayari A, Halaweish FT, Yallapu MM, Chauhan SC, Jaggi M
Sikander M, Hafeez BB, Malik S, Alsayari A, Halaweish FT, Yallapu MM, Chauhan SC, Jaggi M. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer. Sci Rep. 2016 11 08; 6:36594.
Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer.
Adhikari P, Nagesh PKB, Alharthi F, Chauhan SC, Jaggi M, Yallapu MM, Pradhan P
Adhikari P, Nagesh PKB, Alharthi F, Chauhan SC, Jaggi M, Yallapu MM, Pradhan P. Optical detection of the structural properties of tumor tissue generated by xenografting of drug-sensitive and drug-resistant cancer cells using partial wave spectroscopy (PWS). Biomed Opt Express. 2019 Dec 01; 10(12):6422-6431.
Optical detection of the structural properties of tumor tissue generated by xenografting of drug-sensitive and drug-resistant cancer cells using partial wave spectroscopy (PWS).
Gong Y, Chowdhury P, Nagesh PKB, Rahman MA, Zhi K, Yallapu MM, Kumar S
Gong Y, Chowdhury P, Nagesh PKB, Rahman MA, Zhi K, Yallapu MM, Kumar S. Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages. Sci Rep. 2020 03 02; 10(1):3835.
Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages.
Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA, Balabathula P, Behrman SW, Zafar N, Singh MM, Halaweish FT, Jaggi M, Chauhan SC
Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA, Balabathula P, Behrman SW, Zafar N, Singh MM, Halaweish FT, Jaggi M, Chauhan SC. Nanoparticle formulation of ormeloxifene for pancreatic cancer. Biomaterials. 2015; 53:731-43.
Nanoparticle formulation of ormeloxifene for pancreatic cancer.
Chauhan DS, Prasad R, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM
Chauhan DS, Prasad R, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM. Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2. Bioconjug Chem. 2020 09 16; 31(9):2021-2045.
Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2.
Karuri AR, Kashyap VK, Yallapu MM, Zafar N, Kedia SK, Jaggi M, Chauhan SC
Frontiers in bioscience (Scholar edition)
Karuri AR, Kashyap VK, Yallapu MM, Zafar N, Kedia SK, Jaggi M, Chauhan SC. Disparity in rates of HPV infection and cervical cancer in underserved US populations. Front Biosci (Schol Ed). 2017 06 01; 9(2):254-269.
Disparity in rates of HPV infection and cervical cancer in underserved US populations.
Chowdhury P, Roberts AM, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM
Chowdhury P, Roberts AM, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM. Magnetic nanoformulations for prostate cancer. Drug Discov Today. 2017 08; 22(8):1233-1241.
Magnetic nanoformulations for prostate cancer.
Hatami E, Nagesh PKB, Jaggi M, Chauhan SC, Yallapu MM
Hatami E, Nagesh PKB, Jaggi M, Chauhan SC, Yallapu MM. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer. Eur J Pharmacol. 2020 Dec 05; 888:173486.
Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer.
Chauhan N, Jaggi M, Chauhan SC, Yallapu MM
Chauhan N, Jaggi M, Chauhan SC, Yallapu MM. COVID-19: fighting the invisible enemy with microRNAs. Expert Rev Anti Infect Ther. 2021 02; 19(2):137-145.
COVID-19: fighting the invisible enemy with microRNAs.
Yallapu MM, Ebeling MC, Khan S, Sundram V, Chauhan N, Gupta BK, Puumala SE, Jaggi M, Chauhan SC
Yallapu MM, Ebeling MC, Khan S, Sundram V, Chauhan N, Gupta BK, Puumala SE, Jaggi M, Chauhan SC. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther. 2013 Aug; 12(8):1471-80.
Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment.
Kashyap VK, Dhasmana A, Massey A, Kotnala S, Zafar N, Jaggi M, Yallapu MM, Chauhan SC
Kashyap VK, Dhasmana A, Massey A, Kotnala S, Zafar N, Jaggi M, Yallapu MM, Chauhan SC. Smoking and COVID-19: Adding Fuel to the Flame. Int J Mol Sci. 2020 Sep 09; 21(18).
Smoking and COVID-19: Adding Fuel to the Flame.
Varaprasad K, Karthikeyan C, Yallapu MM, Sadiku R
Varaprasad K, Karthikeyan C, Yallapu MM, Sadiku R. The significance of biomacromolecule alginate for the 3D printing of hydrogels for biomedical applications. Int J Biol Macromol. 2022 Jul 01; 212:561-578.
The significance of biomacromolecule alginate for the 3D printing of hydrogels for biomedical applications.
Chavda VP, Soni S, Prajapati R, Yallapu MM, Apostolopoulos V
Chavda VP, Soni S, Prajapati R, Yallapu MM, Apostolopoulos V. Reply to the letter 'Effectiveness of COVID-19 vaccines against Omicron variant'. Immunotherapy. 2022 08; 14(12):905-908.
Reply to the letter 'Effectiveness of COVID-19 vaccines against Omicron variant'.
Adriano B, Cotto NM, Chauhan N, Jaggi M, Chauhan SC, Yallapu MM
Adriano B, Cotto NM, Chauhan N, Jaggi M, Chauhan SC, Yallapu MM. Milk exosomes: Nature's abundant nanoplatform for theranostic applications. Bioact Mater. 2021 Aug; 6(8):2479-2490.
Milk exosomes: Nature's abundant nanoplatform for theranostic applications.
Yallapu MM, Chauhan N, Othman SF, Khalilzad-Sharghi V, Ebeling MC, Khan S, Jaggi M, Chauhan SC
Yallapu MM, Chauhan N, Othman SF, Khalilzad-Sharghi V, Ebeling MC, Khan S, Jaggi M, Chauhan SC. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. Biomaterials. 2015 Apr; 46:1-12.
Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles.
Nagesh PKB, Hatami E, Chowdhury P, Kashyap VK, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM
Nagesh PKB, Hatami E, Chowdhury P, Kashyap VK, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM. Tannic Acid Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in Prostate Cancer. Cancers (Basel). 2018 Mar 07; 10(3).
Tannic Acid Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in Prostate Cancer.
Dhasmana A, Dhasmana S, Kotnala S, Anukriti A, Kashyap VK, Shaji PD, Laskar P, Khan S, Pellicano R, Fagoonee S, Haque S, Yallapu MM, Chauhan SC, Jaggi M
Dhasmana A, Dhasmana S, Kotnala S, Anukriti A, Kashyap VK, Shaji PD, Laskar P, Khan S, Pellicano R, Fagoonee S, Haque S, Yallapu MM, Chauhan SC, Jaggi M. A topography of immunotherapies against gastrointestinal malignancies. Panminerva Med. 2022 Mar; 64(1):56-71.
A topography of immunotherapies against gastrointestinal malignancies.
Dhasmana S, Dhasmana A, Narula AS, Jaggi M, Yallapu MM, Chauhan SC
Dhasmana S, Dhasmana A, Narula AS, Jaggi M, Yallapu MM, Chauhan SC. The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder. Life Sci. 2022 Jan 01; 288:120156.
The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder.
Hama T, Nagesh PK, Chowdhury P, Moore BM, Yallapu MM, Regner KR, Park F
Hama T, Nagesh PK, Chowdhury P, Moore BM, Yallapu MM, Regner KR, Park F. DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity. JCI Insight. 2021 11 22; 6(22).
DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity.
Sikander M, Malik S, Chauhan N, Khan P, Kumari S, Kashyap VK, Khan S, Ganju A, Halaweish FT, Yallapu MM, Jaggi M, Chauhan SC
Sikander M, Malik S, Chauhan N, Khan P, Kumari S, Kashyap VK, Khan S, Ganju A, Halaweish FT, Yallapu MM, Jaggi M, Chauhan SC. Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer. Cancers (Basel). 2019 Mar 14; 11(3).
Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer.
Ganju A, Yallapu MM, Khan S, Behrman SW, Chauhan SC, Jaggi M
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Ganju A, Yallapu MM, Khan S, Behrman SW, Chauhan SC, Jaggi M. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist Updat. 2014 Apr; 17(1-2):13-23.
Nanoways to overcome docetaxel resistance in prostate cancer.
Hatami E, Bhusetty Nagesh PK, Chowdhury P, Elliot S, Shields D, Chand Chauhan S, Jaggi M, Yallapu MM
Hatami E, Bhusetty Nagesh PK, Chowdhury P, Elliot S, Shields D, Chand Chauhan S, Jaggi M, Yallapu MM. Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy. ACS Biomater Sci Eng. 2019 May 13; 5(5):2343-2354.
Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy.
Dhasmana S, Dhasmana A, Khan S, Narula AS, Haque S, Yallapu MM, Chauhan SC
Dhasmana S, Dhasmana A, Khan S, Narula AS, Haque S, Yallapu MM, Chauhan SC. Excessive Urinary p75ecd is a Potential Indicator of Amyotrophic Lateral Sclerosis: An American Cohort Study. Curr Neuropharmacol. 2025; 23(12):1621-1630.
Excessive Urinary p75ecd is a Potential Indicator of Amyotrophic Lateral Sclerosis: An American Cohort Study.
Dan N, Setua S, Kashyap VK, Khan S, Jaggi M, Yallapu MM, Chauhan SC
Dan N, Setua S, Kashyap VK, Khan S, Jaggi M, Yallapu MM, Chauhan SC. Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications. Pharmaceuticals (Basel). 2018 Apr 09; 11(2).
Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications.
Kumar BNP, Puvvada N, Rajput S, Sarkar S, Mahto MK, Yallapu MM, Pathak A, Emdad L, Das SK, Reis RL, Kundu SC, Fisher PB, Mandal M
Kumar BNP, Puvvada N, Rajput S, Sarkar S, Mahto MK, Yallapu MM, Pathak A, Emdad L, Das SK, Reis RL, Kundu SC, Fisher PB, Mandal M. Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer. Mol Pharm. 2018 07 02; 15(7):2698-2713.
Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer.
Yallapu MM, Khan S, Maher DM, Ebeling MC, Sundram V, Chauhan N, Ganju A, Balakrishna S, Gupta BK, Zafar N, Jaggi M, Chauhan SC
Yallapu MM, Khan S, Maher DM, Ebeling MC, Sundram V, Chauhan N, Ganju A, Balakrishna S, Gupta BK, Zafar N, Jaggi M, Chauhan SC. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials. 2014 Oct; 35(30):8635-48.
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
Nagesh PKB, Chowdhury P, Hatami E, Boya VKN, Kashyap VK, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM
Nagesh PKB, Chowdhury P, Hatami E, Boya VKN, Kashyap VK, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM. miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy. Cancers (Basel). 2018 Aug 25; 10(9).
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy.
Moreland R, Arredondo A, Dhasmana A, Dhasmana S, Shabir S, Siddiqua A, Banerjee B, Yallapu MM, Behrman SW, Chauhan SC, Khan S. Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research. Front Pharmacol. 2025; 16:1543112.
Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research.
Reinoza J, Tiwari R, Morales I, Sotelo L, Sengupta D, Hernandez JP, Padilla V, Yallapu MM, Lozano K
Reinoza J, Tiwari R, Morales I, Sotelo L, Sengupta D, Hernandez JP, Padilla V, Yallapu MM, Lozano K. Fabrication of pullulan-chitosan fiber membranes for enhanced hemostatic applications. Int J Biol Macromol. 2025 May; 308(Pt 2):142552.
Fabrication of pullulan-chitosan fiber membranes for enhanced hemostatic applications.
Patel T, Johar P, Kanisetti V, Talacheru S, Avinash V, Das A, Sahu S, Goyal A, Szobody MW, Sayers T, Gullapalli S, Yallapu MM, Shaikh MH, Anand N, Potter-Baker K, Gadad BS
Patel T, Johar P, Kanisetti V, Talacheru S, Avinash V, Das A, Sahu S, Goyal A, Szobody MW, Sayers T, Gullapalli S, Yallapu MM, Shaikh MH, Anand N, Potter-Baker K, Gadad BS. Long-term neurocognitive and behavioral outcomes in survivors of pediatric brain tumors: a systematic review. Front Neurosci. 2025; 19:1587059.
Long-term neurocognitive and behavioral outcomes in survivors of pediatric brain tumors: a systematic review.
Herrara V, Tarab-Ravski D, Chauhan SC, Narang N, Mirazul Islam M, Peer D, Prasad R, Yallapu MM
Herrara V, Tarab-Ravski D, Chauhan SC, Narang N, Mirazul Islam M, Peer D, Prasad R, Yallapu MM. Nanotechnology strategies for endometrium health: Are we on the right track? Bioact Mater. 2025 Dec; 54:423-449.
Nanotechnology strategies for endometrium health: Are we on the right track?
Rao P, Yallapu MM, Sari Y, Fisher PB, Kumar S
Rao P, Yallapu MM, Sari Y, Fisher PB, Kumar S. Designing Novel Nanoformulations Targeting Glutamate Transporter Excitatory Amino Acid Transporter 2: Implications in Treating Drug Addiction. J Pers Nanomed. 2015; 1(1):3-9.
Designing Novel Nanoformulations Targeting Glutamate Transporter Excitatory Amino Acid Transporter 2: Implications in Treating Drug Addiction.
Dhasmana S, Dhasmana A, Kotnala S, Mangtani V, Narula AS, Haque S, Jaggi M, Yallapu MM, Chauhan SC
Dhasmana S, Dhasmana A, Kotnala S, Mangtani V, Narula AS, Haque S, Jaggi M, Yallapu MM, Chauhan SC. Boosting Mitochondrial Potential: An Imperative Therapeutic Intervention in Amyotrophic Lateral Sclerosis. Curr Neuropharmacol. 2023; 21(5):1117-1138.
Boosting Mitochondrial Potential: An Imperative Therapeutic Intervention in Amyotrophic Lateral Sclerosis.
Kumari S, Sikander M, Malik S, Tripathi MK, Hafeez BB, Yallapu MM, Chauhan SC, Khan S, Jaggi M
Kumari S, Sikander M, Malik S, Tripathi MK, Hafeez BB, Yallapu MM, Chauhan SC, Khan S, Jaggi M. Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. Biomedicines. 2021 Dec 02; 9(12).
Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells.
Chavda VP, Kapadia C, Soni S, Prajapati R, Chauhan SC, Yallapu MM, Apostolopoulos V
Chavda VP, Kapadia C, Soni S, Prajapati R, Chauhan SC, Yallapu MM, Apostolopoulos V. A global picture: therapeutic perspectives for COVID-19. Immunotherapy. 2022 04; 14(5):351-371.
A global picture: therapeutic perspectives for COVID-19.
Adriano B, Cotto NM, Chauhan N, Karumuru V, Jaggi M, Chauhan SC, Yallapu MM
Adriano B, Cotto NM, Chauhan N, Karumuru V, Jaggi M, Chauhan SC, Yallapu MM. Bay Leaf Extract-Based Near-Infrared Fluorescent Probe for Tissue and Cellular Imaging. J Imaging. 2021 Nov 30; 7(12).
Bay Leaf Extract-Based Near-Infrared Fluorescent Probe for Tissue and Cellular Imaging.
Kashyap VK, Peasah-Darkwah G, Dhasmana A, Jaggi M, Yallapu MM, Chauhan SC
Kashyap VK, Peasah-Darkwah G, Dhasmana A, Jaggi M, Yallapu MM, Chauhan SC. Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics. Pharmaceutics. 2022 Mar 10; 14(3).
Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics.
Chavda VP, Hanuma Kumar Ghali EN, Yallapu MM, Apostolopoulos V
Chavda VP, Hanuma Kumar Ghali EN, Yallapu MM, Apostolopoulos V. Therapeutics to tackle Omicron outbreak. Immunotherapy. 2022 08; 14(11):833-838.
Therapeutics to tackle Omicron outbreak.
Chowdhury P, Bhusetty Nagesh PK, Hollingsworth TJ, Jaggi M, Chauhan SC, Yallapu MM
Chowdhury P, Bhusetty Nagesh PK, Hollingsworth TJ, Jaggi M, Chauhan SC, Yallapu MM. Coating a Self-Assembly Nanoconstruct with a Neutrophil Cell Membrane Enables High Specificity for Triple Negative Breast Cancer Treatment. ACS Appl Bio Mater. 2022 Aug 17.
Coating a Self-Assembly Nanoconstruct with a Neutrophil Cell Membrane Enables High Specificity for Triple Negative Breast Cancer Treatment.
Kashyap VK, Wang Q, Setua S, Nagesh PKB, Chauhan N, Kumari S, Chowdhury P, Miller DD, Yallapu MM, Li W, Jaggi M, Hafeez BB, Chauhan SC
Journal of experimental & clinical cancer research : CR
Kashyap VK, Wang Q, Setua S, Nagesh PKB, Chauhan N, Kumari S, Chowdhury P, Miller DD, Yallapu MM, Li W, Jaggi M, Hafeez BB, Chauhan SC. Therapeutic efficacy of a novel ?III/?IV-tubulin inhibitor (VERU-111) in pancreatic cancer. J Exp Clin Cancer Res. 2019 Jan 23; 38(1):29.
Therapeutic efficacy of a novel ?III/?IV-tubulin inhibitor (VERU-111) in pancreatic cancer.
Setua S, Khan S, Doxtater K, Yallapu MM, Jaggi M, Chauhan SC
Setua S, Khan S, Doxtater K, Yallapu MM, Jaggi M, Chauhan SC. miR-145: Revival of a Dragon in Pancreatic Cancer. J Nat Sci. 2017 Mar; 3(3).
miR-145: Revival of a Dragon in Pancreatic Cancer.
Kumar S, Sinha N, Gerth KA, Rahman MA, Yallapu MM, Midde NM
Biochemical and biophysical research communications
Kumar S, Sinha N, Gerth KA, Rahman MA, Yallapu MM, Midde NM. Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications. Biochem Biophys Res Commun. 2017 09 23; 491(3):675-680.
Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications.
Hatami E, Mu Y, Shields DN, Chauhan SC, Kumar S, Cory TJ, Yallapu MM
Hatami E, Mu Y, Shields DN, Chauhan SC, Kumar S, Cory TJ, Yallapu MM. Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting. Biochem Biophys Rep. 2019 Mar; 17:197-207.
Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting.
Choppadandi M, Soumya K, Ghosh S, Balu A, Shingote T, Babu SS, Prasanna VS, Arumugam S, Velyutham R, Yallapu MM, Kapusetti G
Choppadandi M, Soumya K, Ghosh S, Balu A, Shingote T, Babu SS, Prasanna VS, Arumugam S, Velyutham R, Yallapu MM, Kapusetti G. Dual Functional Magnetic Nanoparticles Conjugated with Carbon Quantum Dots for Hyperthermia and Photodynamic Therapy for Cancer. Nanotheranostics. 2024; 8(4):442-457.
Dual Functional Magnetic Nanoparticles Conjugated with Carbon Quantum Dots for Hyperthermia and Photodynamic Therapy for Cancer.
Mamidi N, Delgadillo RMV, Sustaita AO, Lozano K, Yallapu MM
Mamidi N, Delgadillo RMV, Sustaita AO, Lozano K, Yallapu MM. Current nanocomposite advances for biomedical and environmental application diversity. Med Res Rev. 2025 Mar; 45(2):576-628.
Current nanocomposite advances for biomedical and environmental application diversity.
Kashyap VK, Nagesh PKB, Singh AK, Massey A, Darkwah GP, George A, Khan S, Hafeez BB, Zafar N, Kumar S, Sinha N, Yallapu MM, Jaggi M, Chauhan SC
Kashyap VK, Nagesh PKB, Singh AK, Massey A, Darkwah GP, George A, Khan S, Hafeez BB, Zafar N, Kumar S, Sinha N, Yallapu MM, Jaggi M, Chauhan SC. Curcumin attenuates smoking and drinking activated NF-?B/IL-6 inflammatory signaling axis in cervical cancer. Cancer Cell Int. 2024 Oct 20; 24(1):343.
Curcumin attenuates smoking and drinking activated NF-?B/IL-6 inflammatory signaling axis in cervical cancer.
Tripathi MK, Zacheaus C, Doxtater K, Keramatnia F, Gao C, Yallapu MM, Jaggi M, Chauhan SC
Tripathi MK, Zacheaus C, Doxtater K, Keramatnia F, Gao C, Yallapu MM, Jaggi M, Chauhan SC. Z Probe, An Efficient Tool for Characterizing Long Non-Coding RNA in FFPE Tissues. Noncoding RNA. 2018 Sep 05; 4(3).
Z Probe, An Efficient Tool for Characterizing Long Non-Coding RNA in FFPE Tissues.
Chowdhury P, Nagesh PKB, Hatami E, Wagh S, Dan N, Tripathi MK, Khan S, Hafeez BB, Meibohm B, Chauhan SC, Jaggi M, Yallapu MM
Chowdhury P, Nagesh PKB, Hatami E, Wagh S, Dan N, Tripathi MK, Khan S, Hafeez BB, Meibohm B, Chauhan SC, Jaggi M, Yallapu MM. Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells. J Colloid Interface Sci. 2019 Feb 01; 535:133-148.
Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.
Varaprasad K, Yallapu MM, N??ez D, Oyarz?n P, L?pez M, Jayaramudu T, Karthikeyan C
Varaprasad K, Yallapu MM, N??ez D, Oyarz?n P, L?pez M, Jayaramudu T, Karthikeyan C. Generation of engineered core-shell antibiotic nanoparticles. RSC Adv. 2019 Mar 14; 9(15):8326-8332.
Generation of engineered core-shell antibiotic nanoparticles.
Chauhan N, Maher DM, Yallapu MM, B Hafeez B, Singh MM, Chauhan SC, Jaggi M
Chauhan N, Maher DM, Yallapu MM, B Hafeez B, Singh MM, Chauhan SC, Jaggi M. A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth. Sci Rep. 2019 07 29; 9(1):10917.
A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth.
Hatami E, Nagesh PKB, Chauhan N, Jaggi M, Chauhan SC, Yallapu MM
Hatami E, Nagesh PKB, Chauhan N, Jaggi M, Chauhan SC, Yallapu MM. In Situ Nanoparticle Self-Assembly for Combination Delivery of Therapeutics to Non-Small Cell Lung Cancer. ACS Appl Bio Mater. 2022 03 21; 5(3):1104-1119.
In Situ Nanoparticle Self-Assembly for Combination Delivery of Therapeutics to Non-Small Cell Lung Cancer.
Hatami E, B Nagesh PK, Sikander M, Dhasmana A, Chauhan SC, Jaggi M, Yallapu MM
Hatami E, B Nagesh PK, Sikander M, Dhasmana A, Chauhan SC, Jaggi M, Yallapu MM. Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells. ACS Omega. 2022 Jul 12; 7(27):23939-23949.
Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells.
Chavda VP, Chen Y, Dave J, Chen ZS, Chauhan SC, Yallapu MM, Uversky VN, Bezbaruah R, Patel S, Apostolopoulos V
Chavda VP, Chen Y, Dave J, Chen ZS, Chauhan SC, Yallapu MM, Uversky VN, Bezbaruah R, Patel S, Apostolopoulos V. COVID-19 and vaccination: myths vs science. Expert Rev Vaccines. 2022 11; 21(11):1603-1620.
COVID-19 and vaccination: myths vs science.
Gong Y, Haque S, Chowdhury P, Cory TJ, Kodidela S, Yallapu MM, Norwood JM, Kumar S
Expert opinion on drug metabolism & toxicology
Gong Y, Haque S, Chowdhury P, Cory TJ, Kodidela S, Yallapu MM, Norwood JM, Kumar S. Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment. Expert Opin Drug Metab Toxicol. 2019 May; 15(5):417-427.
Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment.
Khan S, Setua S, Kumari S, Dan N, Massey A, Hafeez BB, Yallapu MM, Stiles ZE, Alabkaa A, Yue J, Ganju A, Behrman S, Jaggi M, Chauhan SC
Khan S, Setua S, Kumari S, Dan N, Massey A, Hafeez BB, Yallapu MM, Stiles ZE, Alabkaa A, Yue J, Ganju A, Behrman S, Jaggi M, Chauhan SC. Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. Biomaterials. 2019 07; 208:83-97.
Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer.
Yallapu MM, Teniente J, Tsin A, Chauhan SC
Yallapu MM, Teniente J, Tsin A, Chauhan SC. Highlights from International Conference on Cancer Health Disparities 2021. Cancer Health Disparities. 2022; 6.
Highlights from International Conference on Cancer Health Disparities 2021.